Innovation & Expertise
Gamma Biosciences is a leading life sciences company providing products and services to support the development and manufacturing of advanced biologic therapies. Our operating companies are committed to advancing the science and art of bioprocessing by delivering market-ready innovation and expertise that helps our customers, mainly biopharmaceutical companies and contract development and manufacturing companies, safely bring therapies to patients more quickly and efficiently. Gamma is a global company with offices and major manufacturing facilities in North America, the U.K. and Belgium.
Chief Executive OfficerRead Bio
Chief Executive Officer
Matt oversees the Gamma portfolio and is responsible for identifying and executing investments as well as driving growth, strategic and operational initiatives and business development activities at Gamma’s portfolio companies. Matt was most recently Global Head of Business Development for GE Healthcare, where he was responsible for M&A and strategic alliances across the $19B division of GE. Matt joined GE in 2011 and held a variety of other leadership positions in strategy, business development, venture investing and new business creation during his nearly nine years at the company. Matt began his career as a corporate attorney at Sidley Austin LLP. He holds a J.D. from the University of Michigan and a B.A. in Economics from Georgetown University.
Phil Vanek, PhD
Chief Technology OfficerRead Bio
Phil Vanek, PhD
Chief Technology Officer
Phil is responsible for technical due diligence and evaluation of potential investments, as well as guiding operational, R&D and strategic initiatives carried out at portfolio companies. An entrepreneurial and strategic international business leader, Phil joins Gamma from GE Healthcare’s Cell and Gene Therapy business unit where he directed strategy and portfolio growth. Phil received his Ph.D. in Biochemistry and Molecular Biology at Georgetown University Medical Center followed by an IRTA fellowship at the National Cancer Institute in Maryland, and at the Hollings Cancer Center in Charleston, SC. Phil was an instructor for Johns Hopkins University Advanced Academic Programs teaching Biotechnology Marketing in the Masters of Biotechnology / MBA program, and has held leadership positions in a number of life sciences companies including Life Technologies, Becton Dickinson, and Lonza. Phil is a Board Member of CCRM in Toronto Canada and a Board Member of the ARM Foundation.
Chief Commercial OfficerRead Bio
Chief Commercial Officer
Gabe leads global commercial operations and business responsibilities across North America, UK, Europe, and Asia. He also oversees expansion of Astrea’s growing product line in emerging markets. Gabe brings more than 25 years of commercial experience in life sciences and biotherapeutics, developing high performance sales & marketing teams and establishing commercial excellence programs to accelerate profitability and growth; all while championing the customer experience.
Most recently Gabe built a Global Commercial team at Horizon Discovery, leading customer-facing operations and strategy, and establishing a performance-driven Key Account program resulting in over 50% YOY revenue growth. Prior to Horizon, he held several senior roles focused on commercial acceleration and sales success at Danaher Corporation operating companies Molecular Devices LLC, Leica BioSystems and Genetix Ltd. He also previously held multiple sales, marketing, and product management roles with Ventana Medical Systems Inc., a member of the Roche Group.
Vice PresidentRead Bio
Eric focuses on financial diligence and deal execution for new investments, and ongoing portfolio management. Prior to joining Gamma Eric led product management for Zymergen, a biomanufacturing company, where he oversaw technology development for new capabilities including bioinformatics and data science. Eric began his career as a consultant with Bain & Company, advising on technology strategy and M&A due diligence. He holds a B.S. in Materials Science Engineering and Economics from Northwestern University and an MBA from Harvard Business School.